Digital health platform Tata 1mg launches its first Reference Lab in Delhi

Tata 1mg, India's largest digital health platform today announced the launch of its first Reference Lab based in Delhi, which was inaugurated by Dr. Indu Bhushan - Former CEO, Ayushman Bharat.

Published On 2022-03-18 11:30 GMT   |   Update On 2022-03-19 05:10 GMT

New Delhi: Tata 1mg, India's largest digital health platform today announced the launch of its first Reference Lab based in Delhi, which was inaugurated by Dr. Indu Bhushan - Former CEO, Ayushman Bharat. The state of the art reference diagnostics laboratory enables an extensive catalog of tests, can process upto 4000 tests an hour and joins Tata 1mg's already extensive nationwide network of 8 diagnostic labs that serve over a million customers each year, across 30 cities.

Since its foray into e-diagnostics in 2016, Tata 1mg has established itself as one of India's leading diagnostics players, earning consumer trust and loyalty, by consistently delivering a superlative experience. The brand enjoys one of the highest customer satisfaction scores in the healthcare industry, on the back of industry-leading on-time collection rates, fast report delivery, clinically robust processes and a highly professional and trained team.

Speaking about Tata 1mg's continued thrust on diagnostics, Ayushman Bharat, Former CEO, Ayushman Bharat and Chief Guest at the inauguration of the Reference Lab said, "Timely and high quality diagnostic tests form the backbone of the decision-making process while managing the health journey of patients. It is important for private organizations like Tata 1mg to strongly participate in ensuring seamless accessibility of quality healthcare across the nation. I'm confident that Tata 1mg's network will strengthen access to providing best-in-class diagnostic services to every patient's doorstep."

Speaking about their vision, Gaurav Agarwal, Co-Founder, Tata 1mg said, "Opening of a reference lab is an important milestone in Tata 1mg's journey towards becoming India's most trusted diagnostics brand. Our new lab provides us with an ability to expand our range of services while staying synonymous with reliability, trustworthiness and convenience. We are humbled by the trust millions of customers have shown in our existing healthcare services and we will continue to further strengthen our offerings and grow our network and expertise, to become the first choice of healthcare brand for consumers, doctors and caregivers across the country."

The new Reference Lab in Delhi is spread across 24000 sq. feet area and is equipped to process more than 4000 tests per hour across pathology and microbiology specializations. Tata 1mg's network of labs works with best in class quality assurance and provides a comprehensive range of routine, specialized and esoteric tests covering the whole spectrum of clinical diagnostics. Technology-enabled and fully automated systems track end to end sample movement from collection to reporting, thus eliminating pre-analytical errors. The labs are led by a strong and highly experienced team of pathologists, microbiologists, biochemists and molecular scientists who are further supported by the brand's existing network of 1000+ phlebotomists for home sample collection.

Read Also - 1MG majority stake to be acquired by Tata Digital



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News